Single-Cell Profiling of Bone Marrow B Cells and Early B Cell Developmental Disorders Associated With Systemic Lupus Erythematosus
© 2023 The Authors. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology..
OBJECTIVE: The peripheral B cell compartment is heavily disturbed in systemic lupus erythematosus (SLE), but whether B cells develop aberrantly in the bone marrow (BM) is largely unknown.
METHODS: We performed single-cell RNA/B cell receptor (BCR) sequencing and immune profiling of BM B cells and classified patients with SLE into two groups: early B cell (Pro-B and Pre-B) normal (EBnor) and EB defective/low (EBlo) groups.
RESULTS: The SLE-EBlo group exhibited more severe disease activity and proinflammatory status, overaction of type I interferon signaling and metabolic pathways within the B cell compartment, and aberrant BCR repertoires compared with the SLE-EBnor group. Moreover, in one patient with SLE who was initially classified in the SLE-EBlo group, early B cell deficiency and associated abnormalities were largely rectified in a second BM sample at the remission phase.
CONCLUSION: In summary, this study suggests that early B cell loss in BM defines a unique pathological state in a subset of patients with SLE that may play an active role in the dysregulated autoimmune responses.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
---|---|
Enthalten in: |
Arthritis & rheumatology (Hoboken, N.J.) - 76(2024), 4 vom: 27. März, Seite 599-613 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Dong, Chen [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 28.03.2024 Date Revised 28.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/art.42750 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364383356 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364383356 | ||
003 | DE-627 | ||
005 | 20240329000135.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/art.42750 |2 doi | |
028 | 5 | 2 | |a pubmed24n1353.xml |
035 | |a (DE-627)NLM364383356 | ||
035 | |a (NLM)37946666 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Dong, Chen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Single-Cell Profiling of Bone Marrow B Cells and Early B Cell Developmental Disorders Associated With Systemic Lupus Erythematosus |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.03.2024 | ||
500 | |a Date Revised 28.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology. | ||
520 | |a OBJECTIVE: The peripheral B cell compartment is heavily disturbed in systemic lupus erythematosus (SLE), but whether B cells develop aberrantly in the bone marrow (BM) is largely unknown | ||
520 | |a METHODS: We performed single-cell RNA/B cell receptor (BCR) sequencing and immune profiling of BM B cells and classified patients with SLE into two groups: early B cell (Pro-B and Pre-B) normal (EBnor) and EB defective/low (EBlo) groups | ||
520 | |a RESULTS: The SLE-EBlo group exhibited more severe disease activity and proinflammatory status, overaction of type I interferon signaling and metabolic pathways within the B cell compartment, and aberrant BCR repertoires compared with the SLE-EBnor group. Moreover, in one patient with SLE who was initially classified in the SLE-EBlo group, early B cell deficiency and associated abnormalities were largely rectified in a second BM sample at the remission phase | ||
520 | |a CONCLUSION: In summary, this study suggests that early B cell loss in BM defines a unique pathological state in a subset of patients with SLE that may play an active role in the dysregulated autoimmune responses | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Guo, Yicheng |e verfasserin |4 aut | |
700 | 1 | |a Chen, Zechuan |e verfasserin |4 aut | |
700 | 1 | |a Li, Teng |e verfasserin |4 aut | |
700 | 1 | |a Ji, Juan |e verfasserin |4 aut | |
700 | 1 | |a Sun, Chi |e verfasserin |4 aut | |
700 | 1 | |a Li, Jing |e verfasserin |4 aut | |
700 | 1 | |a Cao, Haixia |e verfasserin |4 aut | |
700 | 1 | |a Xia, Yunfei |e verfasserin |4 aut | |
700 | 1 | |a Xue, Zhonghui |e verfasserin |4 aut | |
700 | 1 | |a Gu, Xixi |e verfasserin |4 aut | |
700 | 1 | |a Liang, Qian |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Rui |e verfasserin |4 aut | |
700 | 1 | |a Fu, Ting |e verfasserin |4 aut | |
700 | 1 | |a Ma, Jiaqiang |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Shan |e verfasserin |4 aut | |
700 | 1 | |a Wu, Chunmei |e verfasserin |4 aut | |
700 | 1 | |a Fu, Qiong |e verfasserin |4 aut | |
700 | 1 | |a Guo, Genkai |e verfasserin |4 aut | |
700 | 1 | |a Bao, Yanfeng |e verfasserin |4 aut | |
700 | 1 | |a Guo, Hua |e verfasserin |4 aut | |
700 | 1 | |a Yang, Junling |e verfasserin |4 aut | |
700 | 1 | |a Xu, Min |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xiaoming |e verfasserin |4 aut | |
700 | 1 | |a Sheng, Zizhang |e verfasserin |4 aut | |
700 | 1 | |a Gu, Zhifeng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Arthritis & rheumatology (Hoboken, N.J.) |d 2014 |g 76(2024), 4 vom: 27. März, Seite 599-613 |w (DE-627)NLM234543671 |x 2326-5205 |7 nnns |
773 | 1 | 8 | |g volume:76 |g year:2024 |g number:4 |g day:27 |g month:03 |g pages:599-613 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/art.42750 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 76 |j 2024 |e 4 |b 27 |c 03 |h 599-613 |